Mithra Pharmaceuticals S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
17,677.00
19,038.00
20,435.00
22,468.00
46,252.00
57,876
Cost of Goods Sold (COGS) incl. D&A
9,599.00
10,620.00
10,195.00
9,029.00
9,095.00
1,571
Gross Income
8,078.00
8,418.00
10,240.00
13,439.00
37,157.00
56,305
SG&A Expense
8,730.00
11,730.00
24,829.00
50,092.00
61,577.00
46,669
EBIT
652.00
3,312.00
14,589.00
36,653.00
24,420.00
9,636
Unusual Expense
-
-
3,084.00
3,537.00
19,393.00
46,550
Non Operating Income/Expense
98.00
384.00
331.00
721.00
3,708.00
4,788
Interest Expense
178.00
226.00
798.00
1,256.00
6,329.00
5,365
Pretax Income
732.00
3,154.00
11,857.00
40,603.00
46,426.00
37,491
Income Tax
759.00
293.00
4,794.00
5,548.00
11,420.00
9,885
Equity in Affiliates
37.00
94.00
2,758.00
32.00
-
-
Consolidated Net Income
1,528.00
2,955.00
9,821.00
35,087.00
35,006.00
27,606
Net Income
1,528.00
2,955.00
9,821.00
35,087.00
35,006.00
27,606
Net Income After Extraordinaries
1,528.00
2,955.00
9,821.00
35,087.00
35,006.00
42,849
Net Income Available to Common
1,528.00
2,955.00
9,821.00
35,087.00
35,006.00
12,363
EPS (Basic)
0.25
0.49
0.39
1.13
1.07
0.34
Basic Shares Outstanding
6,023.80
6,023.80
25,405.70
31,129.80
32,660.20
36,564.70
EPS (Diluted)
0.25
0.49
0.39
1.13
1.07
0.34
Diluted Shares Outstanding
6,023.80
6,023.80
25,405.70
31,129.80
32,660.20
36,564.70
EBITDA
61.00
2,573.00
13,912.00
35,667.00
22,139.00
12,487
Non-Operating Interest Income
-
-
115.00
122.00
8.00
-
About Mithra Pharmaceuticals
View Profile
